;

Home >>

Global Prostate Cancer Market Report 2020 by Key Players Types Applications Countries Market Size Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Published: Sep-2020 | Format: PDF | Maia Research | Number of pages: 128 | Code: MRS - 773908

The Prostate Cancer market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Prostate Cancer market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Prostate Cancer market. The report focuses on well-known providers in the global Prostate Cancer industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Prostate Cancer Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Prostate Cancer market covered in Chapter 4:
Bayer AG
Indevus Pharmaceuticals Inc.
BioMark Diagnostics Inc.
Astellas Pharma Inc.
Abbott
AstraZeneca
Sanofi
Dendreon Inc.
TOLMAR Pharmaceuticals Inc.
Ipsen
Cellanyx LLC
Ferring BV

In Chapter 11 and 13.3, on the basis of types, the Prostate Cancer market from 2015 to 2026 is primarily split into:
Hormonal Therapy
Chemotherapy
Targeted Therapy
Immunotherapy

In Chapter 12 and 13.4, on the basis of applications, the Prostate Cancer market from 2015 to 2026 covers:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Prostate Cancer Market Share by Type (2020-2026)
1.5.2 Hormonal Therapy
1.5.3 Chemotherapy
1.5.4 Targeted Therapy
1.5.5 Immunotherapy
1.6 Market by Application
1.6.1 Global Prostate Cancer Market Share by Application (2020-2026)
1.6.2 Hospital Pharmacy
1.6.3 Retail Pharmacy
1.6.4 Online Pharmacy
1.7 Prostate Cancer Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Prostate Cancer Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Prostate Cancer Market
3.1 Value Chain Status
3.2 Prostate Cancer Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Prostate Cancer
3.2.3 Labor Cost of Prostate Cancer
3.2.3.1 Labor Cost of Prostate Cancer Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Bayer AG
4.1.1 Bayer AG Basic Information
4.1.2 Prostate Cancer Product Profiles, Application and Specification
4.1.3 Bayer AG Prostate Cancer Market Performance (2015-2020)
4.1.4 Bayer AG Business Overview
4.2 Indevus Pharmaceuticals Inc.
4.2.1 Indevus Pharmaceuticals Inc. Basic Information
4.2.2 Prostate Cancer Product Profiles, Application and Specification
4.2.3 Indevus Pharmaceuticals Inc. Prostate Cancer Market Performance (2015-2020)
4.2.4 Indevus Pharmaceuticals Inc. Business Overview
4.3 BioMark Diagnostics Inc.
4.3.1 BioMark Diagnostics Inc. Basic Information
4.3.2 Prostate Cancer Product Profiles, Application and Specification
4.3.3 BioMark Diagnostics Inc. Prostate Cancer Market Performance (2015-2020)
4.3.4 BioMark Diagnostics Inc. Business Overview
4.4 Astellas Pharma Inc.
4.4.1 Astellas Pharma Inc. Basic Information
4.4.2 Prostate Cancer Product Profiles, Application and Specification
4.4.3 Astellas Pharma Inc. Prostate Cancer Market Performance (2015-2020)
4.4.4 Astellas Pharma Inc. Business Overview
4.5 Abbott
4.5.1 Abbott Basic Information
4.5.2 Prostate Cancer Product Profiles, Application and Specification
4.5.3 Abbott Prostate Cancer Market Performance (2015-2020)
4.5.4 Abbott Business Overview
4.6 AstraZeneca
4.6.1 AstraZeneca Basic Information
4.6.2 Prostate Cancer Product Profiles, Application and Specification
4.6.3 AstraZeneca Prostate Cancer Market Performance (2015-2020)
4.6.4 AstraZeneca Business Overview
4.7 Sanofi
4.7.1 Sanofi Basic Information
4.7.2 Prostate Cancer Product Profiles, Application and Specification
4.7.3 Sanofi Prostate Cancer Market Performance (2015-2020)
4.7.4 Sanofi Business Overview
4.8 Dendreon Inc.
4.8.1 Dendreon Inc. Basic Information
4.8.2 Prostate Cancer Product Profiles, Application and Specification
4.8.3 Dendreon Inc. Prostate Cancer Market Performance (2015-2020)
4.8.4 Dendreon Inc. Business Overview
4.9 TOLMAR Pharmaceuticals Inc.
4.9.1 TOLMAR Pharmaceuticals Inc. Basic Information
4.9.2 Prostate Cancer Product Profiles, Application and Specification
4.9.3 TOLMAR Pharmaceuticals Inc. Prostate Cancer Market Performance (2015-2020)
4.9.4 TOLMAR Pharmaceuticals Inc. Business Overview
4.10 Ipsen
4.10.1 Ipsen Basic Information
4.10.2 Prostate Cancer Product Profiles, Application and Specification
4.10.3 Ipsen Prostate Cancer Market Performance (2015-2020)
4.10.4 Ipsen Business Overview
4.11 Cellanyx LLC
4.11.1 Cellanyx LLC Basic Information
4.11.2 Prostate Cancer Product Profiles, Application and Specification
4.11.3 Cellanyx LLC Prostate Cancer Market Performance (2015-2020)
4.11.4 Cellanyx LLC Business Overview
4.12 Ferring BV
4.12.1 Ferring BV Basic Information
4.12.2 Prostate Cancer Product Profiles, Application and Specification
4.12.3 Ferring BV Prostate Cancer Market Performance (2015-2020)
4.12.4 Ferring BV Business Overview

5 Global Prostate Cancer Market Analysis by Regions
5.1 Global Prostate Cancer Sales, Revenue and Market Share by Regions
5.1.1 Global Prostate Cancer Sales by Regions (2015-2020)
5.1.2 Global Prostate Cancer Revenue by Regions (2015-2020)
5.2 North America Prostate Cancer Sales and Growth Rate (2015-2020)
5.3 Europe Prostate Cancer Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Prostate Cancer Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Prostate Cancer Sales and Growth Rate (2015-2020)
5.6 South America Prostate Cancer Sales and Growth Rate (2015-2020)

6 North America Prostate Cancer Market Analysis by Countries
6.1 North America Prostate Cancer Sales, Revenue and Market Share by Countries
6.1.1 North America Prostate Cancer Sales by Countries (2015-2020)
6.1.2 North America Prostate Cancer Revenue by Countries (2015-2020)
6.1.3 North America Prostate Cancer Market Under COVID-19
6.2 United States Prostate Cancer Sales and Growth Rate (2015-2020)
6.2.1 United States Prostate Cancer Market Under COVID-19
6.3 Canada Prostate Cancer Sales and Growth Rate (2015-2020)
6.4 Mexico Prostate Cancer Sales and Growth Rate (2015-2020)

7 Europe Prostate Cancer Market Analysis by Countries
7.1 Europe Prostate Cancer Sales, Revenue and Market Share by Countries
7.1.1 Europe Prostate Cancer Sales by Countries (2015-2020)
7.1.2 Europe Prostate Cancer Revenue by Countries (2015-2020)
7.1.3 Europe Prostate Cancer Market Under COVID-19
7.2 Germany Prostate Cancer Sales and Growth Rate (2015-2020)
7.2.1 Germany Prostate Cancer Market Under COVID-19
7.3 UK Prostate Cancer Sales and Growth Rate (2015-2020)
7.3.1 UK Prostate Cancer Market Under COVID-19
7.4 France Prostate Cancer Sales and Growth Rate (2015-2020)
7.4.1 France Prostate Cancer Market Under COVID-19
7.5 Italy Prostate Cancer Sales and Growth Rate (2015-2020)
7.5.1 Italy Prostate Cancer Market Under COVID-19
7.6 Spain Prostate Cancer Sales and Growth Rate (2015-2020)
7.6.1 Spain Prostate Cancer Market Under COVID-19
7.7 Russia Prostate Cancer Sales and Growth Rate (2015-2020)
7.7.1 Russia Prostate Cancer Market Under COVID-19

8 Asia-Pacific Prostate Cancer Market Analysis by Countries
8.1 Asia-Pacific Prostate Cancer Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Prostate Cancer Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Prostate Cancer Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Prostate Cancer Market Under COVID-19
8.2 China Prostate Cancer Sales and Growth Rate (2015-2020)
8.2.1 China Prostate Cancer Market Under COVID-19
8.3 Japan Prostate Cancer Sales and Growth Rate (2015-2020)
8.3.1 Japan Prostate Cancer Market Under COVID-19
8.4 South Korea Prostate Cancer Sales and Growth Rate (2015-2020)
8.4.1 South Korea Prostate Cancer Market Under COVID-19
8.5 Australia Prostate Cancer Sales and Growth Rate (2015-2020)
8.6 India Prostate Cancer Sales and Growth Rate (2015-2020)
8.6.1 India Prostate Cancer Market Under COVID-19
8.7 Southeast Asia Prostate Cancer Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Prostate Cancer Market Under COVID-19

9 Middle East and Africa Prostate Cancer Market Analysis by Countries
9.1 Middle East and Africa Prostate Cancer Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Prostate Cancer Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Prostate Cancer Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Prostate Cancer Market Under COVID-19
9.2 Saudi Arabia Prostate Cancer Sales and Growth Rate (2015-2020)
9.3 UAE Prostate Cancer Sales and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Sales and Growth Rate (2015-2020)
9.5 Nigeria Prostate Cancer Sales and Growth Rate (2015-2020)
9.6 South Africa Prostate Cancer Sales and Growth Rate (2015-2020)

10 South America Prostate Cancer Market Analysis by Countries
10.1 South America Prostate Cancer Sales, Revenue and Market Share by Countries
10.1.1 South America Prostate Cancer Sales by Countries (2015-2020)
10.1.2 South America Prostate Cancer Revenue by Countries (2015-2020)
10.1.3 South America Prostate Cancer Market Under COVID-19
10.2 Brazil Prostate Cancer Sales and Growth Rate (2015-2020)
10.2.1 Brazil Prostate Cancer Market Under COVID-19
10.3 Argentina Prostate Cancer Sales and Growth Rate (2015-2020)
10.4 Columbia Prostate Cancer Sales and Growth Rate (2015-2020)
10.5 Chile Prostate Cancer Sales and Growth Rate (2015-2020)

11 Global Prostate Cancer Market Segment by Types
11.1 Global Prostate Cancer Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Prostate Cancer Sales and Market Share by Types (2015-2020)
11.1.2 Global Prostate Cancer Revenue and Market Share by Types (2015-2020)
11.2 Hormonal Therapy Sales and Price (2015-2020)
11.3 Chemotherapy Sales and Price (2015-2020)
11.4 Targeted Therapy Sales and Price (2015-2020)
11.5 Immunotherapy Sales and Price (2015-2020)

12 Global Prostate Cancer Market Segment by Applications
12.1 Global Prostate Cancer Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Prostate Cancer Sales and Market Share by Applications (2015-2020)
12.1.2 Global Prostate Cancer Revenue and Market Share by Applications (2015-2020)
12.2 Hospital Pharmacy Sales, Revenue and Growth Rate (2015-2020)
12.3 Retail Pharmacy Sales, Revenue and Growth Rate (2015-2020)
12.4 Online Pharmacy Sales, Revenue and Growth Rate (2015-2020)

13 Prostate Cancer Market Forecast by Regions (2020-2026)
13.1 Global Prostate Cancer Sales, Revenue and Growth Rate (2020-2026)
13.2 Prostate Cancer Market Forecast by Regions (2020-2026)
13.2.1 North America Prostate Cancer Market Forecast (2020-2026)
13.2.2 Europe Prostate Cancer Market Forecast (2020-2026)
13.2.3 Asia-Pacific Prostate Cancer Market Forecast (2020-2026)
13.2.4 Middle East and Africa Prostate Cancer Market Forecast (2020-2026)
13.2.5 South America Prostate Cancer Market Forecast (2020-2026)
13.3 Prostate Cancer Market Forecast by Types (2020-2026)
13.4 Prostate Cancer Market Forecast by Applications (2020-2026)
13.5 Prostate Cancer Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing